Tirzepatide 10mg — Complete Research Guide, Dosing & Reconstitution
Dual GLP-1/GIP mechanism, reconstitution math, storage, published outcomes and sourcing for Tirzepatide research.
Research use only. All products discussed are sold strictly for laboratory research. Not for human or animal consumption, diagnosis, cure, or treatment. No dosing or administration guidance is provided.
Tirzepatide is a dual GLP-1 / GIP receptor agonist and one of the most-cited metabolic peptides in current research.
Mechanism
GIP potentiates insulin secretion and improves adipose glucose handling; GLP-1 slows gastric emptying and modulates appetite signaling. The synergy produced ~22% body-weight reduction at 72 weeks in SURMOUNT-1's 15 mg arm.
> For laboratory and research use only. Not for human consumption, diagnostic, or therapeutic use. All statements below summarize preclinical and academic literature.
Frequently asked questions
How much BAC water for a 10 mg vial?
1–2 mL; 2 mL yields 5 mg/mL for easy measurement.
Stability after reconstitution?
~30 days refrigerated at 2–8 °C.
International shipping?
Yes — express tracked from US and Turkey.
Purity?
≥99% HPLC verified.
Same as Retatrutide?
No — Tirzepatide is a dual agonist; Retatrutide adds glucagon receptor activity.
COA?
Yes, on request.
Research use only. All products discussed are sold strictly for laboratory research. Not for human or animal consumption, diagnosis, cure, or treatment. No dosing or administration guidance is provided.